Minisymposium
Coeliac disease and malignancy

https://doi.org/10.1016/S1590-8658(02)80198-0Get rights and content

Abstract

The development of malignancy, particularly lymphoma, is the most serious complication to affect patients with coeliac disease. Although the association has been known for about 40 years, there are still gaps in our understanding. The prevalence of lymphoma and why only some coeliac patients develop this are not clear but environmental and genetic factors must be at work. Based on data from a large coeliac clinic in Derby, about 55 lymphomas per year would arise in the coeliac population of the United Kingdom, of which half would affect the small bowel. Whether patients with coeliac disease who have atypical or no symptoms at diagnosis, are at the same risk as those who are diagnosed as a result of classical symptoms as was more the case in the past, is not known. Some patients, however, do have coeliac disease and lymphoma diagnosed at the same presentation. This consideration has implications for initiating screening programmes to detect coeliac disease and thus offer patients a gluten-free diet early that would help to reduce the risk of lymphoma from developing. In this context, case-finding rather than blanket population screening is to be recommended on present evidence. Research into the role of intraepithelial lymphocytes in the genesis of lymphoma has indicated that non-responsive coeliac disease (refractory spruej and ulcerative jejunoileitis (ulcerative jejunitis) are part of the lymphoma spectrum. The diagnosis of lymphoma can be difficult and the prognosis, in general, is poor, although with modern chemotherapeutic regimes and surgery in selected cases, long-term survival is possible. The best option is to try and prevent lymphoma from arising by advising all patients to adhere to a strict gluten-free diet. Malignant complications of coeliac disease are uncommon but will continue to challenge clinicians and clinical scientists. Unravelling the mechanisms that contribute to the development of lymphoma and other tumours in coeliac disease may well contribute to a wider understanding of oncogenesis.

References (73)

  • F. Carbonnel et al.

    Are complicated forms of celiac disease cryptic Tcell lymphomas?

    Blood

    (1998)
  • E. Bagdi et al.

    Mucosal intra-epithelial lymphocytes in enteropathy-associated Tcell lymphoma, ulcerative jejunitis, and refractory celiac disease constitute a neoplastic population

    Blood

    (1999)
  • C. Matuchansky et al.

    Cavitation in mesenteric lymph nodes, splenic atrophy, and a flat small intestinal mucosa

    Gastroenterology

    (1984)
  • H.J. Freeman et al.

    Small bowel malignant lymphoma complicating celiac sprue and the mesenteric lymph node cavitation syndrome

    Gastroenterology

    (1986)
  • W.M. Howell et al.

    HLA-DRB, -DQA, and -DQB polymorphism in coeliac disease and enteropathy-associated T-cell lymphoma. Common features and additional risk factors for malignancy

    Hum Immunol

    (1995)
  • M. Congia et al.

    A gene dosage effect of the DQA1∗0501/DQB1∗0201 allelic combination influences the clinical heterogeneity of coeliac disease

    Hum Immunol

    (1994)
  • H.J. Freeman et al.

    Multifocal small bowel lymphoma and latent coeliac sprue

    Gastroenterology

    (1986)
  • K.R. Gough et al.

    Intestinal reticulosis as a complication of idiopathic steatorrhoea

    Gut

    (1962)
  • W.I. Austad et al.

    Steatorrhoea and malignant lymphoma. The relationship between malignant tumours of lymphoid tissue and coeliac disease

    Am J Dig Dis

    (1967)
  • G.K.T. Holmes et al.

    Coeliac disease, gluten free diet and malignancy

    Gut

    (1976)
  • Case records of the Massachussetts General Hospital

    New Engl J Med

    (1958)
  • C. O'Farrelly et al.

    Humoral response to wheat protein in patients with coeliac disease and enteropathy associated T cell lymphoma

    Br Med J

    (1986)
  • The non-Hodgkin's Lymphoma Classification Project

    A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma

    Blood

    (1997)
  • G.K.T. Holmes et al.

    Malignancy as a complication of coeliac disease

  • H. Hin et al.

    Coeliac disease in primary care: case finding study

    Br Med J

    (1999)
  • S.D. Johnson et al.

    Coeliac disease detected by screening is not silent — simply unrecognized

    Q J Med

    (1998)
  • B.R.C. O'Driscoll et al.

    HLA type of patients with coeliac disease and malignancy in the west of Ireland

    Gut

    (1982)
  • M. Ilyas et al.

    Non-Hodgkin's lymphoma, coeliac disease, and Epstein-Barr virus: a study of 13 cases of enteropathy-associated T and B-cell lymphoma

    J Pathol

    (1995)
  • L.J. Egan et al.

    Coeliac-associated lymphoma

    J Clin Gastroenterol

    (1995)
  • L. Brandt et al.

    Lymphoma of the small intestine in adult coeliac disease

    Acta Med Scand

    (1978)
  • W.S. Selby et al.

    Malignancy in a 19 year experience of adult coeliac disease

    Dig Dis Sci

    (1979)
  • O.H. Nielsen et al.

    Non-tropical sprue. Malignant disease and mortality rate

    Scand J Gastroenterol

    (1995)
  • P. Collin et al.

    Coeliac disease — associated disorders and survival

    Gut

    (1994)
  • M. Cottone et al.

    Mortality and causes of death in celiac disease in a Mediterranean area

    Dig Dis Sci

    (1999)
  • A. Ferguson et al.

    Coeliac disease and malignancies

    Acta Paediatr

    (1996)
  • F. Delco et al.

    Celiac sprite among US Military Veterans. Associated disorders and clinical manifestations

    Dig Dis Sci

    (1999)
  • Cited by (42)

    • New/Revised Entities in Gastrointestinal Lymphoproliferative Disorders

      2019, Surgical Pathology Clinics
      Citation Excerpt :

      The pathogenesis of EATL is strongly associated with celiac disease/gluten sensitive enteropathy and is a feared complication of this condition.10–14 Patients demonstrate higher levels of antiendomysial (or antitissue transglutaminase 2) antibodies, HLA-DQ2 or HLA-DQ8 alleles, and dermatitis herpetiformis,15 and demonstrate gluten sensitivity with a protective effect of gluten-free diet.4,12,16–26 Risk factors linked to EATL are duration and dose of gluten exposure, advanced age,7,23–25 and HLA-DQ2 allele homozygosity.4,23,26

    • T-cell/NK-cell lymphomas: A review

      2007, Cancer Letters
      Citation Excerpt :

      Patients with known celiac disease should adhere to a gluten-free diet. Treatment with a gluten-free diet might decrease the risk of lymphoma, implicating chronic antigenic stimulation as a causal factor [85]. Small bowel perforation or obstruction, gastrointestinal bleeding, and enterocoelic fistulas are recognized complications of this disease [83].

    • Abdominal CT findings may suggest coeliac disease

      2005, Digestive and Liver Disease
    View all citing articles on Scopus
    View full text